These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33307558)

  • 21. Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors.
    Almeida MQ; Fragoso MC; Lotfi CF; Santos MG; Nishi MY; Costa MH; Lerario AM; Maciel CC; Mattos GE; Jorge AA; Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3524-31. PubMed ID: 18611974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis.
    Cheng JY; Brown TC; Murtha TD; Stenman A; Juhlin CC; Larsson C; Healy JM; Prasad ML; Knoefel WT; Krieg A; Scholl UI; Korah R; Carling T
    BMC Cancer; 2017 Mar; 17(1):164. PubMed ID: 28249601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DAX-1 expression in human adrenocortical neoplasms: implications for steroidogenesis.
    Reincke M; Beuschlein F; Lalli E; Arlt W; Vay S; Sassone-Corsi P; Allolio B
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2597-600. PubMed ID: 9661652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De novo steroid biosynthesis in human prostate cell lines and biopsies.
    Sakai M; Martinez-Arguelles DB; Aprikian AG; Magliocco AM; Papadopoulos V
    Prostate; 2016 May; 76(6):575-87. PubMed ID: 26841972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DAX1 Overexpression in Pediatric Adrenocortical Tumors: A Synergic Role with SF1 in Tumorigenesis.
    de Sousa GR; Soares IC; Faria AM; Domingues VB; Wakamatsu A; Lerario AM; Alves VA; Zerbini MC; Mendonca BB; Fragoso MC; Latronico AC; Almeida MQ
    Horm Metab Res; 2015 Aug; 47(9):656-61. PubMed ID: 25985323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis.
    Leal LF; Bueno AC; Gomes DC; Abduch R; de Castro M; Antonini SR
    Oncotarget; 2015 Dec; 6(40):43016-32. PubMed ID: 26515592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of Osthole on Adrenocortical Function in Y1 Mouse Adrenocortical Tumor Cells].
    Pan ZQ; Liang LL; Fang ZQ; Liu XM; Lu WL; Zhang YY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 May; 36(5):574-9. PubMed ID: 27386650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discerning malignancy in adrenocortical tumors: are molecular markers useful?
    Wachenfeld C; Beuschlein F; Zwermann O; Mora P; Fassnacht M; Allolio B; Reincke M
    Eur J Endocrinol; 2001 Sep; 145(3):335-41. PubMed ID: 11517015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells.
    Wong DH; Villanueva JA; Cress AB; Sokalska A; Ortega I; Duleba AJ
    Fertil Steril; 2011 Nov; 96(5):1252-8. PubMed ID: 21907337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined steroidogenic characters of fetal adrenal and Leydig cells in childhood adrenocortical carcinoma.
    Fujisawa Y; Sakaguchi K; Ono H; Yamaguchi R; Kato F; Kagami M; Fukami M; Ogata T
    J Steroid Biochem Mol Biol; 2016 May; 159():86-93. PubMed ID: 26940356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
    Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms.
    Norman KL; Sarnow P
    J Virol; 2010 Jan; 84(1):666-70. PubMed ID: 19846523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early embryonic lethality caused by targeted disruption of the 3-hydroxy-3-methylglutaryl-CoA reductase gene.
    Ohashi K; Osuga J; Tozawa R; Kitamine T; Yagyu H; Sekiya M; Tomita S; Okazaki H; Tamura Y; Yahagi N; Iizuka Y; Harada K; Gotoda T; Shimano H; Yamada N; Ishibashi S
    J Biol Chem; 2003 Oct; 278(44):42936-41. PubMed ID: 12920113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptome analysis of adrenocortical cancers: from molecular classification to the identification of new treatments.
    Ragazzon B; Assié G; Bertherat J
    Endocr Relat Cancer; 2011 Apr; 18(2):R15-27. PubMed ID: 21208995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.
    Mo H; Elson CE
    Exp Biol Med (Maywood); 2004 Jul; 229(7):567-85. PubMed ID: 15229351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome.
    Ronchi CL; Sbiera S; Altieri B; Steinhauer S; Wild V; Bekteshi M; Kroiss M; Fassnacht M; Allolio B
    Endocr Relat Cancer; 2015 Aug; 22(4):531-43. PubMed ID: 25979380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors.
    Fonseca AL; Kugelberg J; Starker LF; Scholl U; Choi M; Hellman P; Åkerström G; Westin G; Lifton RP; Björklund P; Carling T
    Genes Chromosomes Cancer; 2012 Oct; 51(10):949-60. PubMed ID: 22733721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroidogenic acute regulatory protein mRNA expression in adrenal tumours.
    Zenkert S; Schubert B; Fassnacht M; Beuschlein F; Allolio B; Reincke M
    Eur J Endocrinol; 2000 Mar; 142(3):294-9. PubMed ID: 10700725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the mevalonate pathway of isoprenoid synthesis in IL-8 generation by activated monocytic cells.
    Terkeltaub R; Solan J; Barry M; Santoro D; Bokoch GM
    J Leukoc Biol; 1994 Jun; 55(6):749-55. PubMed ID: 8195701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The balance between induction and inhibition of mevalonate pathway regulates cancer suppression by statins: A review of molecular mechanisms.
    Ahmadi Y; Ghorbanihaghjo A; Argani H
    Chem Biol Interact; 2017 Aug; 273():273-285. PubMed ID: 28668359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.